In 2016, the BioPhorum IT (BPIT) collaboration group created the original Digital Plant Maturity Model (DPMM) and high-level Assessment Tool to help you conduct single-plant and manufacturing-network assessments with a high degree of consistency. It described five maturity levels ranging from manual paper-based to the fully automated ‘adaptive’ plant of the future.
Driven by the need to reflect progress made in available technologies and new business models, and lift the maturity levels as more factories adopt Industry 4.0 principles, we have updated and refreshed the DPMM Assessment Tool and associated guidance.
The updated DPMM Assessment Tool is a structured and straightforward way to assess the digital maturity of your plants and set a target maturity level aligned with your company’s digital strategy. Companies can easily adopt the tool to support benchmarking and investment decisions. Adopting the DPMM 3.0 and the Assessment Tool can increase your digital maturity and give you the flexibility to carry out a quick plant assessment at
one site or a more detailed assessment across multiple plants.
Version 3.0 has an increased focus on quality with two new dimensions: ‘quality control’ and ‘Quality Management Systems’. ‘Process development’ is a new dimension emphasizing technology transfer and the previous ‘IT Security and Operations’ dimension has been revised. ‘Cybersecurity’ now focuses on applying proper security controls to protect the availability, integrity, and confidentiality of systems that operate up to an adaptive digital plant level.
“If you are looking for a comprehensive model that gives you a clear digital picture of your network, the DPMM is the one to adopt,” said Yves Berthouzoz, Head of IT Biotech Operations and CMC Development at Merck. “It is simple, clear, and provides a view across all your sites. The five levels allow you to not only understand your current digital maturity but also build your digital strategy and ask for support from your sponsors. Additionally, if you need help, it gives you the right insight on how to progress in your digital journey.”
Two new papers support the updated Assessment Tool.
This explains the development of the DPMM 3.0 and the Assessment Tool and reflects how industry has changed since the first DPMM. For example, what a ‘good’ connected or predictive plant looked like five years ago has changed because industry and technology have evolved. The DPMM 3.0 has been developed to cover what is possible today and define a vision that is beyond the capabilities of current manufacturing and IT technologies.
This sets out the intended use of the DPMM and Assessment Tool to support digital maturity assessments, identify capabilities to develop, create strategic plans and roadmaps, influence technology suppliers, and develop human resource competency and development frameworks.
We demonstrate the need for using such a tool for plant assessments in manufacturing and detail the refreshed five levels of maturity to identify the commonalities within the industry. It describes two approaches to using the assessment tool – quick and detailed – while sharing learning and indicating future direction.
In developing the DPMM, we have formulated a set of transformational milestones for bringing disruption and innovation to an inherently risk-averse and highly regulated environment. Biopharmaceutical manufacturers and their technology suppliers can now chart their progress using these milestones. The alignment between the DPMM and the BioPhorum Biomanufacturing Technology Roadmap will help ensure that your digital roadmap is aligned with transformative advances in how medicines are made.
In defining today’s needs for advanced-level adaptive plants that are beyond current technologies, the DPMM 3.0 provides a robust platform to identify and develop digital strategies for manufacturing to ensure a reliable supply of transformative medicines to patients worldwide. For more information, download the tool and supporting papers here or email email@example.com with your feedback.